Neurostatus Systems AG

Neurostatus
News

Neurostatus Systems AG
Close

Neurostatus
News

Neurostatus e-Scoring increases EDSS consistency up to 99.7%

Neurostatus e-Scoring increases EDSS consistency up to 99.7% compared to the paper assessment method (82%).

Read more in this article published on LinkedIn and attend the oral presentation of Neurostatus e-Scoring system performance results at ECTRIMS 2015:

"Neurostatus e-Scoring (NESC): first experience in a phase 3 clinical trial with siponimod (BAF312) in secondary progressive multiple sclerosis (EXPAND)"
M.D'Souza et al.

Session Title: Parallel Session 2 - New challenges in clinical trial design
Session Date: Thursday, 8 October 2015
Presenting Time: 11:49 - 12:01